Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention

Intravenous unfractionated heparin (UFH) is the most frequently used anticoagulant for percutaneous coronary intervention (PCI). Intravenous enoxaparin, a low-molecular weight heparin, has superior pharmacokinetic and pharmacodynamic properties compared with UFH. Multiple trials have shown enoxaparin to be safe and effective in PCI. However, there has not been a contemporary study evaluating its safety and efficacy. To assess its efficacy and safety, intravenous enoxaparin during PCI via radial artery access was evaluated in PCI patients from Jan 2015 to Dec 2019.

Source: The American Journal of Cardiology - February 29, 2024 Category: Cardiology Authors: Hani Alturkmani, Barry Uretsky, Swetal Patel, Mu'nes Albadaineh, Omar Alqaisi, Malek Alaiwah, Michael Cross, Danish Abbasi, William Rollefson Source Type: research